Jpmorgan Chase & Co »

Inozyme Pharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $147k 34k 4.27
2023-09-30 $92k 22k 4.20
2023-06-30 $147k 26k 5.57
2023-03-31 $0 60 0.00
2022-12-31 $0 60 0.00
2022-06-30 $0 60 0.00
2022-03-31 $1.3M 311k 4.10
2021-12-31 $2.2M 324k 6.84
2021-03-31 $421k 21k 19.73
2020-12-31 $79k 3.8k 20.57
2020-09-30 $72k 3.0k 23.77